CRP and type 2 diabetes mellitus: Accordingly, to fully elucidate the long‐term clinical relevance of low‐carbohydrate diets, future randomized trials should emphasize the assessment of hard endpoints, including cardiovascular events, type 2 diabetes incidence, and all‐cause mortality rather than relying exclusively on surrogate markers like CRP.